跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
TROGARZO 200 mg CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
TROGARZO 200 mg CONCENTRADO PARA SOLUCION PARA PERFUSION
Theratechnologies Europe Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 16, 2021
Approval ID
ac3a6ae6fd1713b1
Company
Theratechnologies Europe Limited
Type
Standard
Approval Details
Approval Id
ac3a6ae6fd1713b1
Drug Cima Aemps Name
TROGARZO 200 mg CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1191359001
Holder Company Name
Theratechnologies Europe Limited
Marketing Company Name
Theratechnologies Europe Limited
Authorization Date
2021-03-16
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
200 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Theratechnologies Europe Limited
Active Ingredients
IBALIZUMAB
200 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 16, 2021
Approval ID
ac3a6ae6fd1713b1
Type
Standard
Back to CIMA-AEMPS Approvals
TROGARZO 200 mg CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
